Clinical Scorecard: Glaucoma Care Moves Beyond the Clinic
At a Glance
| Category | Detail |
|---|---|
| Condition | Glaucoma |
| Key Mechanisms | Home monitoring technology for intraocular pressure (IOP) and disease progression. |
| Target Population | Patients with glaucoma requiring monitoring of IOP fluctuations. |
| Care Setting | Home and clinical settings. |
Key Highlights
- Emerging tools for home tonometry and perimetry enhance disease monitoring.
- iCare Home rebound tonometer approved for home IOP monitoring by FDA.
- Home monitoring can influence treatment decisions and assess intervention success.
- Virtual reality perimetry shows promise but lacks standardization.
- Artificial intelligence may aid in data management for individualized care.
Guideline-Based Recommendations
Diagnosis
- Utilize home tonometry for continuous IOP monitoring.
- Incorporate virtual reality perimetry as a supplementary tool.
Management
- Adjust medications based on home IOP data.
- Consider laser therapy or surgery based on monitoring results.
Monitoring & Follow-up
- Regularly assess IOP using home monitoring devices.
- Combine home tonometry with perimetry for comprehensive monitoring.
Risks
- Usability issues with home monitoring devices may affect patient compliance.
- Accuracy may vary based on corneal thickness and extreme pressure levels.
Patient & Prescribing Data
Patients with glaucoma requiring ongoing IOP assessment.
Home monitoring data can lead to timely adjustments in treatment plans.
Clinical Best Practices
- Encourage patient education on the use of home monitoring devices.
- Integrate home monitoring data into routine clinical assessments.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.